{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:37:50Z","timestamp":1776757070616,"version":"3.51.2"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomarkers in Neuropsychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bionps.2025.100120","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T19:33:04Z","timestamp":1738092784000},"page":"100120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Tapas K.","family":"Sur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanmoy","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarish","family":"Noreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jheannelle","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Nunlee-Bland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Loffredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent E.","family":"Korba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha S.","family":"Jana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Kwabi-Addo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somiranjan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bionps.2025.100120_bib1","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer\u2019s disease facts and figures, 2021. Alzheimers Dement 17, 327\u2013406. https:\/\/doi.org\/10.1002\/alz.12328.","DOI":"10.1002\/alz.12328"},{"key":"10.1016\/j.bionps.2025.100120_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1192\/bjp.bp.110.086405","article-title":"Prevalence of dementia in African\u2013Caribbean compared with UK-born White older people: two-stage cross-sectional study","volume":"199","author":"Adelman","year":"2011","journal-title":"Br. Psychiatry"},{"key":"10.1016\/j.bionps.2025.100120_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12967-023-04088-5","article-title":"The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus","volume":"21","author":"A\u011fag\u00fcnd\u00fcz","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.bionps.2025.100120_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/bs.pmbts.2016.12.019","article-title":"Mitochondrial perturbation in Alzheimer\u2019s disease and diabetes","volume":"146","author":"Akhter","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib5","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jnnp.2009.199950","article-title":"CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson\u2019s disease: the Norwegian ParkWest study","volume":"81","author":"Alves","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bionps.2025.100120_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.bionps.2025.100120_bib7","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.20.2.233","article-title":"Kinesin gene variability may affect tau phosphorylation in early Alzheimer\u2019s disease","author":"Andersson","year":"2007","journal-title":"Int J. Mol. Med 20, 233\u2013239"},{"key":"10.1016\/j.bionps.2025.100120_bib8","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1523\/JNEUROSCI.19-11-04421.1999","article-title":"Role of phosphorylation of Alzheimer\u2019s amyloid precursor protein during neuronal differentiation","volume":"19","author":"Ando","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib9","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2022.85","article-title":"Blood biomarkers from research use to clinical practice: what must be done? a report from the EU\/US CTAD task force","author":"Angioni","year":"2022","journal-title":"J. Prev. Alz Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib10","unstructured":"Apolipoprotein E (APOE) Genotype - Clinical test - NIH Genetic Testing Registry (GTR) - NCBI [WWW Document], n.d. URL \u3008https:\/\/www.ncbi.nlm.nih.gov\/gtr\/tests\/classic\/293420\/\u3009 (accessed 6.19.24)."},{"key":"10.1016\/j.bionps.2025.100120_bib11","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.3390\/ijms231810847","article-title":"Peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) expression in a clinical population of Pakistani patients with type 2 diabetes and dyslipidemia","volume":"23","author":"Arif","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/biomedicines10040778","article-title":"Type 2 diabetes mellitus as a risk factor for Alzheimer\u2019s disease: review and meta-analysis","volume":"10","author":"Athanasaki","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bionps.2025.100120_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jgs.13314","article-title":"Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer\u2019s disease","volume":"63","author":"Aubert","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bionps.2025.100120_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2016.03.005","article-title":"Diabetes and Alzheimer\u2019s disease crosstalk","volume":"64","author":"Baglietto-Vargas","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bionps.2025.100120_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification","volume":"12","author":"Barth\u00e9lemy","year":"2020","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.bionps.2025.100120_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","article-title":"CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease","volume":"3","author":"Barth\u00e9lemy","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib17","first-page":"975","article-title":"Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid\u2013Alzheimer\u2019s disease relationships?","volume":"1801","author":"Beel","year":"2010","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bionps.2025.100120_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet"},{"key":"10.1016\/j.bionps.2025.100120_bib19","article-title":"Aducanumab therapy to treat Alzheimer\u2019s disease: a narrative review","volume":"2022","author":"Beshir","year":"2022","journal-title":"Int J. Alzheimers Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2014.00002","article-title":"Increased microRNA-34c abundance in Alzheimer\u2019s disease circulating blood plasma","volume":"7","author":"Bhatnagar","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.bionps.2025.100120_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000249145","article-title":"Cerebrospinal fluid total tau is associated with shorter survival in dementia with lewy bodies","volume":"28","author":"Bostr\u00f6m","year":"2009","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bionps.2025.100120_bib24","article-title":"Clinical application of CSF biomarkers for Alzheimer\u2019s disease: from rationale to ratios","volume":"14","author":"Bouwman","year":"2022","journal-title":"Alz amp; Dem Diag Ass amp; Dis. Mo"},{"key":"10.1016\/j.bionps.2025.100120_bib25","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","article-title":"Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer's Disease: a comparative Overview","volume":"50","author":"Brosseron","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bionps.2025.100120_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer\u2019s disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.bionps.2025.100120_bib28","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-191092","article-title":"The Prevalence of dementia: a systematic review and meta-analysis","volume":"73","author":"Cao","year":"2020","journal-title":"JAD"},{"key":"10.1016\/j.bionps.2025.100120_bib29","unstructured":"CDC, 2024. Alzheimer Diseaseas [WWW Document]. URL \u3008https:\/\/www.cdc.gov\/nchs\/fastats\/alzheimers.htm\u3009 (accessed 6.19.24)."},{"key":"10.1016\/j.bionps.2025.100120_bib30","unstructured":"CDC, 2024. National Diabetes Statistics Report [WWW Document]. Diabetes. URL \u3008https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html\u3009 (accessed 6.18.24)."},{"key":"10.1016\/j.bionps.2025.100120_bib31","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","article-title":"Epidemiology of Alzheimer\u2019s disease and other forms of dementia in China, 1990\u20132010: a systematic review and analysis","volume":"381","author":"Chan","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bionps.2025.100120_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and Type 2 diabetes: a critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.trci.2018.08.009","article-title":"Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States","volume":"4","author":"Chen","year":"2018","journal-title":"AD Transl. Res Clin. Inter."},{"key":"10.1016\/j.bionps.2025.100120_bib34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/mp.2014.127","article-title":"Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment","volume":"20","author":"Cheng","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bionps.2025.100120_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.bionps.2025.100120_bib36","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/molecules25102439","article-title":"The Positive Side of the Alzheimer\u2019s disease amyloid cross-interactions: the case of the A\u03b2 1-42 peptide with Tau, TTR, CysC, and ApoA1","volume":"25","author":"Ciccone","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bionps.2025.100120_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-017-0093-5","article-title":"Role of BACE1 in Alzheimer\u2019s synaptic function","volume":"6","author":"Das","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bionps.2025.100120_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11597760-000000000-00000","article-title":"Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer\u02bcs disease","volume":"72","author":"De La Monte","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bionps.2025.100120_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","article-title":"The role of ABCA7 in Alzheimer\u2019s disease: evidence from genomics, transcriptomics and methylomics","volume":"138","author":"De Roeck","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bionps.2025.100120_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jnc.15166","article-title":"Alzheimer\u2019s disease and type 2 diabetes mellitus: a systematic review of proteomic studies","volume":"156","author":"Diniz Pereira","year":"2021","journal-title":"J. Neurochem"},{"key":"10.1016\/j.bionps.2025.100120_bib41","article-title":"Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer\u2019s continuum","volume":"14","author":"Dor\u00e9","year":"2022","journal-title":"Alz amp; Dem Diag Ass amp; Dis. Mo"},{"key":"10.1016\/j.bionps.2025.100120_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.14283\/jpad.2019.30","article-title":"The 2018 Revised FDA guidance for early Alzheimer\u2019s disease: establishing the meaningfulness of treatment effects","volume":"6","author":"Edgar","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jalz.2009.05.663","article-title":"The FAS gene, brain volume, and disease progression in Alzheimer\u2019s disease","volume":"6","author":"Erten-Lyons","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11011-021-00754-z","article-title":"Alzheimer\u2019s disease: a step closer to understanding type 3 diabetes in African Americans","volume":"36","author":"Ferguson","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11011-019-00512-2","article-title":"Increased inflammation in BA21 brain tissue from African Americans with Alzheimer\u2019s disease","volume":"35","author":"Ferguson","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer's disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bionps.2025.100120_bib48","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/acn3.51763","article-title":"Independent study demonstrates amyloid probability score accurately indicates amyloid pathology","volume":"10","author":"Fogelman","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.dadm.2019.05.001","article-title":"Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Fossati","year":"2019","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.bionps.2025.100120_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib51","unstructured":"Gauthier, S., Rosa-Neto, P., A. Morais, J., Webster, C., nd World Alzheimer Report 2021, Journey through the diagnosis of dementia. Alzheimer\u2019s Disease International, London, England."},{"key":"10.1016\/j.bionps.2025.100120_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137532","article-title":"Alzheimer\u2019s disease: The role of proteins in formation, mechanisms, and new therapeutic approaches","volume":"817","author":"Gholami","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bionps.2025.100120_bib53","unstructured":"Ghosh, S.G., Loffredo, C.A., Noreen, Z., Simhadri, J.J., Nnanabu, T., Bhatti, A., Nunlee-Blnad, G., Jana, S.S., Chandra, V., 2020. Global Gene Expression of the Alzheimer\u2019s Diseases Pathophysiology in South-East Asian Population. Presented at the AAIC Neuroscience Next, ALZ."},{"key":"10.1016\/j.bionps.2025.100120_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease:: getting on and staying on","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr. Ther. Res Clin. Exp."},{"key":"10.1016\/j.bionps.2025.100120_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer\u2019s disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib56","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archneur.59.4.588","article-title":"Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease","volume":"59","author":"Haan","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.arr.2017.03.002","article-title":"In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings","volume":"36","author":"Hall","year":"2017","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.bionps.2025.100120_bib58","first-page":"388","article-title":"Neuroinflammation in Alzheimer disease","volume":"14","author":"Heneka","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.bionps.2025.100120_bib59","article-title":"The link between diabetes mellitus and tau hyperphosphorylation: implications for risk of Alzheimer\u2019s disease","author":"Hobday","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.bionps.2025.100120_bib60","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8392","article-title":"Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment","volume":"5","author":"Hu","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bionps.2025.100120_bib61","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bionps.2025.100120_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4236\/aad.2022.112002","article-title":"Alzheimer\u2019s disease (AD): risks, treatments, prevention, and future implementations","volume":"11","author":"Huma","year":"2022","journal-title":"AAD"},{"key":"10.1016\/j.bionps.2025.100120_bib63","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins","volume":"58","author":"Huynh","year":"2017","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.bionps.2025.100120_bib64","doi-asserted-by":"crossref","first-page":"426","DOI":"10.14283\/jpad.2023.43","article-title":"Diagnostic biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease: an overview of tests for clinical practice in the United States and Europe","volume":"10","author":"Iaccarino","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib66","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib67","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/alz.12395","article-title":"Detecting amyloid positivity in early Alzheimer\u2019s disease using combinations of plasma A\u03b242\/A\u03b240 and p-tau","volume":"18","author":"Janelidze","year":"2022","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib70","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbadis.2016.06.015","article-title":"Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration","volume":"1863","author":"Jha","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib71","unstructured":"Jheannelle Johnson, Zarish Noreen, Tanmoy Mondal, Loffredo, C.A., Korbe, B., Nunlee-Bland, G., Jyothirmai Simhadri, Sharliene Cotin, Quartey, R., Howell, C.D., Chandra, V., Sidhartha S.Jana, Somiranjan Ghosh, 2022. Understanding Pathogenesis of Alzheimer\u2019s Disease Type II Diabetes Mellitus Patients using Pathway Profiler Array (qRT-PCR): A Case Study. https:\/\/doi.org\/10.13140\/RG.2.2.27850.79044."},{"key":"10.1016\/j.bionps.2025.100120_bib72","unstructured":"Johnson, J.; Mondal, T.; Noreen, Z.; Cotin, S.T.; Newheart, M.; Saleebaan, A.; Bentley, F.; Swain, C.; Ghosh, S.; et al. A conceptual framework of type II diabetes mellitus and Alzheimer\u2019s disease in African Americans. ABRCMS, Anaheim, CA; Nov 9-12, 2022."},{"issue":"2","key":"10.1016\/j.bionps.2025.100120_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bionps.2025.100120_bib74","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.3390\/ijms21093272","article-title":"Combination drug therapy for the management of Alzheimer\u2019s disease","volume":"21","author":"Kabir","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib75","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer\u2019s disease a Type 3 Diabetes? a critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib76","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer\u2019s Disease","volume":"21","author":"Kao","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.bionps.2025.100120_bib77","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","article-title":"Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers","volume":"71","author":"Kester","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cca.2021.05.011","article-title":"The PrecivityADTM test: Accurate and reliable LC-MS\/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis","volume":"519","author":"Kirmess","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bionps.2025.100120_bib79","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","article-title":"The National Institute on aging and the Alzheimer\u2019s association research framework for alzheimer\u2019s disease: perspectives from the research roundtable","volume":"14","author":"Knopman","year":"2018","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib80","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/cells12040602","article-title":"Alzheimer\u2019s disease-associated alternative splicing of CD33 IS REGULATEd by the HNRNPA family proteins","volume":"12","author":"Komuro","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bionps.2025.100120_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet"},{"key":"10.1016\/j.bionps.2025.100120_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","article-title":"CSF p-tau205: a biomarker of tau pathology in Alzheimer\u2019s disease","volume":"147","author":"Lantero-Rodriguez","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bionps.2025.100120_bib83","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/s41598-020-60595-1","article-title":"Prediction of Alzheimer\u2019s disease using blood gene expression data","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bionps.2025.100120_bib84","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.bionps.2025.100120_bib85","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/joim.12164","article-title":"The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer\u2019s disease","volume":"275","author":"Li","year":"2014","journal-title":"J. Intern Med"},{"key":"10.1016\/j.bionps.2025.100120_bib86","article-title":"Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer disease amyloid plaques","volume":"98","author":"Li","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bionps.2025.100120_bib87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12974-018-1148-y","article-title":"TREM2 regulates innate immunity in Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bionps.2025.100120_bib89","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/alz.12528","article-title":"Risk of Alzheimer\u2019s disease and related dementia by sex and race\/ethnicity: the multiethnic cohort study","volume":"18","author":"Lim","year":"2022","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib90","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/CIA.S357558","article-title":"Neuroinflammation as a potential therapeutic target in Alzheimer's disease","volume":"17","author":"Liu","year":"2022","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.bionps.2025.100120_bib92","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","article-title":"Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42","volume":"60","author":"Maddalena","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib93","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/med.21534","article-title":"Involvement of calpain in the neuropathogenesis of Alzheimer\u2019s disease","volume":"39","author":"Mahaman","year":"2019","journal-title":"Med Res Rev."},{"key":"10.1016\/j.bionps.2025.100120_bib94","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/biomedicines10040850","article-title":"Development of Alzheimer\u2019s disease biomarkers: from CSF- to blood-based biomarkers","volume":"10","author":"Mankhong","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bionps.2025.100120_bib95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-170309","article-title":"Understanding the link between dementia and diabetes","volume":"59","author":"Martins","year":"2017","journal-title":"JAD"},{"key":"10.1016\/j.bionps.2025.100120_bib96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-022-01124-2","article-title":"Lecanemab in patients with early Alzheimer\u2019s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","volume":"14","author":"McDade","year":"2022","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.bionps.2025.100120_bib97","unstructured":"Medications for Memory, Cognition and Dementia-Related Behaviors [WWW Document], n.d. URL \u3008https:\/\/www.alz.org\/alzheimers-dementia\/treatments\/medications-for-memory\u3009 (accessed 6.18.24)."},{"key":"10.1016\/j.bionps.2025.100120_bib98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jalz.2016.09.002","article-title":"Two novel loci, COBL and SLC10A2, for Alzheimer\u2019s disease in African Americans","volume":"13","author":"Mez","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib99","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2013.07.027","article-title":"Association of cerebrospinal fluid A\u03b242 with A2M gene in cognitively normal subjects","volume":"35","author":"Millard","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib101","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-130203","article-title":"The AD-CSF-index discriminates Alzheimer\u2019s disease patients from healthy controls: a validation study","volume":"36","author":"Molinuevo","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib102","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/acn3.51863","article-title":"A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment","volume":"10","author":"Monane","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3589","article-title":"Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area","volume":"39","author":"Mondal","year":"2023","journal-title":"Diabetes Metab. Res Rev."},{"issue":"1","key":"10.1016\/j.bionps.2025.100120_bib104","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3233\/ADR-230146","article-title":"Transcriptomic analysis of Alzheimer\u2019s disease pathways in a Pakistani population","volume":"8","author":"Mondal","year":"2024","journal-title":"ADR"},{"key":"10.1016\/j.bionps.2025.100120_bib105","doi-asserted-by":"crossref","first-page":"16654","DOI":"10.3390\/ijms242316654","article-title":"Transcriptomics of MASLD pathobiology in African American Patients in the Washington DC Area","volume":"24","author":"Mondal","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.bionps.2025.100120_bib106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/CEOR.S146788","article-title":"Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer\u2019s disease in Japan","volume":"10","author":"Montgomery","year":"2018","journal-title":"Clin. Outcomes Res"},{"key":"10.1016\/j.bionps.2025.100120_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.846902","article-title":"Most pathways can be related to the pathogenesis of Alzheimer\u2019s disease","volume":"14","author":"Morgan","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib108","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer disease","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib109","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bionps.2025.100120_bib111","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/ijms21093165","article-title":"Type 3 diabetes and its role implications in Alzheimer\u2019s disease","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib112","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/alz.12092","article-title":"Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer\u2019s pathology","volume":"16","author":"Nho","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib113","first-page":"523","article-title":"Prevalence and incidence of Alzheimer\u2019s disease in Europe: a meta-analysis. Neurologia","volume":"32","author":"Niu","year":"2017"},{"key":"10.1016\/j.bionps.2025.100120_bib114","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/ijerph15081582","article-title":"Epidemiological investigation of type 2 diabetes and Alzheimer\u2019s disease in a Pakistani population","volume":"15","author":"Noreen","year":"2018","journal-title":"IJERPH"},{"key":"10.1016\/j.bionps.2025.100120_bib115","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.3390\/ijerph17165866","article-title":"Transcriptional profiling and biological pathway(s) analysis of type 2 diabetes mellitus in a Pakistani population","volume":"17","author":"Noreen","year":"2020","journal-title":"IJERPH"},{"key":"10.1016\/j.bionps.2025.100120_bib116","article-title":"Similarities in pathobiology of Alzheimer\u2019s disease and type 2 diabetes mellitus: a proof of concept by a case study","volume":"19","author":"Noreen","year":"2023","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer\u2019s disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib118","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.bionps.2025.100120_bib119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","article-title":"Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients","volume":"183","author":"Olsson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(02)01022-4","article-title":"Association analysis between Alzheimer\u2019s disease and the Nicastrin gene polymorphisms","volume":"333","author":"Orlacchio","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bionps.2025.100120_bib121","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bionps.2025.100120_bib122","article-title":"Type 2 diabetes mellitus and Alzheimer\u2019s Disease: a review of the potential links","volume":"18","author":"Pakdin","year":"2022","journal-title":"CDR"},{"key":"10.1016\/j.bionps.2025.100120_bib123","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","article-title":"Genetic cause of hyperglycaemia and response to treatment in diabetes","volume":"362","author":"Pearson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bionps.2025.100120_bib124","first-page":"1","article-title":"Diagnosis of early Alzheimer\u2019s Disease: clinical practice in 2021","author":"Porsteinsson","year":"2021","journal-title":"J. Prev. Alz Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.25246","article-title":"Combined neuropathological pathways account for age-related risk of dementia","volume":"84","author":"Power","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-019-03553-4","article-title":"AGE\u2013RAGE stress: a changing landscape in pathology and treatment of Alzheimer\u2019s disease","volume":"459","author":"Prasad","year":"2019","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.bionps.2025.100120_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152342","article-title":"Identification of differentially expressed genes through integrated study of Alzheimer\u2019s disease affected brain regions","volume":"11","author":"Puthiyedth","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bionps.2025.100120_bib128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.bionps.2025.100120_bib129","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/alz.12801","article-title":"Alzheimer's disease neuroimaging initiative and the Swedish BioFINDER study. Clinical performance and robustness evaluation of plasma amyloid-\u03b242\/40 prescreening","volume":"19","author":"Rabe","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neurobiolaging.2018.02.024","article-title":"Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid \u03b2-peptide levels, without discernable behavioral effects in an APP\/PS1 mutant transgenic mouse model of Alzheimer\u2019s disease","volume":"66","author":"Raefsky","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2018.07.216","article-title":"Prevalence and incidence of clinically diagnosed Alzheimer\u2019s disease dementia from 1994 to 2012 in a population study","volume":"15","author":"Rajan","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib132","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","article-title":"Microglia-mediated synapse loss in Alzheimer\u2019s disease","volume":"38","author":"Rajendran","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib133","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2018.10.022","article-title":"CSF soluble TREM2 as a measure of immune response along the Alzheimer\u2019s disease continuum","volume":"74","author":"Rauchmann","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib134","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bionps.2025.100120_bib135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","article-title":"The development and convergence of co-pathologies in Alzheimer's disease","volume":"144","author":"Robinson","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.bionps.2025.100120_bib136","doi-asserted-by":"crossref","first-page":"h3029","DOI":"10.1136\/bmj.h3029","article-title":"Dementia: timely diagnosis and early intervention","volume":"350","author":"Robinson","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.bionps.2025.100120_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.bionps.2025.100120_bib138","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.bionps.2025.100120_bib139","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11064-018-2690-9","article-title":"Diabetes and Alzheimer\u2019s disease: a link not as simple as it seems","volume":"44","author":"Salas","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bionps.2025.100120_bib140","series-title":"in: Comprehensive Precision Medicine","first-page":"511","article-title":"Development of early biomarkers of Alzheimer\u2019s disease: A precision medicine perspective","author":"Sarkar","year":"2024"},{"key":"10.1016\/j.bionps.2025.100120_bib141","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jalz.2015.05.009","article-title":"Genetic studies of quantitative MCI and AD phenotypes in ADNI: progress, opportunities, and plans","volume":"11","author":"Saykin","year":"2015","journal-title":"Alzheimer\u2019S. amp; Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib142","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bionps.2025.100120_bib143","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.bionps.2025.100120_bib144","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200358","article-title":"Effect of race on prediction of brain amyloidosis by plasma A\u03b242\/A\u03b240, phosphorylated tau, and neurofilament light","volume":"99","author":"Schindler","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bionps.2025.100120_bib145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/359325a0","article-title":"Isolation and quantification of soluble Alzheimer\u2019s beta-peptide from biological fluids","volume":"359","author":"Seubert","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bionps.2025.100120_bib146","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib147","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41398-021-01709-9","article-title":"Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer\u2019s amyloid, tau and FDG PET status","volume":"11","author":"Shen","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bionps.2025.100120_bib148","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased plasma beta-secretase 1 May predict conversion to Alzheimer\u2019s disease dementia in individuals with mild cognitive impairment","volume":"83","author":"Shen","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bionps.2025.100120_bib149","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","article-title":"Alzheimer\u2019s disease: risk factors and potentially protective measures","volume":"26","author":"Silva","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib150","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.neuroimage.2012.08.002","article-title":"Identification of gene pathways implicated in Alzheimer\u2019s disease using longitudinal imaging phenotypes with sparse regression","volume":"63","author":"Silver","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.bionps.2025.100120_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110211","article-title":"Biomarkers of metabolic disorders and neurobehavioral diseases in a PCB- exposed population: what we learned and the implications for future research","volume":"191","author":"Simhadri","year":"2020","journal-title":"Environ. Res"},{"key":"10.1016\/j.bionps.2025.100120_bib152","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bionps.2025.100120_bib153","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","article-title":"Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer\u2019s disease: the effect of APOE epsilon4 allele","volume":"56","author":"Sunderland","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bionps.2025.100120_bib154","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-161277","article-title":"Higher peripheral TREM2 mRNA levels relate to cognitive deficits and hippocampal atrophy in alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"58","author":"Tan","year":"2017","journal-title":"JAD"},{"key":"10.1016\/j.bionps.2025.100120_bib155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib156","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"the European Alzheimer\u2019s Disease Initiative Investigators","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.bionps.2025.100120_bib157","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib158","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bionps.2025.100120_bib159","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1654","article-title":"Noninvasive characterization of Alzheimer\u2019s disease by circulating, cell-free messenger RNA next-generation sequencing","volume":"6","author":"Toden","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bionps.2025.100120_bib160","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/genes13071176","article-title":"Overview of transcriptomic research on type 2 diabetes: challenges and perspectives","volume":"13","author":"Tonyan","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.bionps.2025.100120_bib161","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4161\/cc.1.4.139","article-title":"The dephosphorylated form of the anaphase-promoting complex protein Cdc27\/Apc3 concentrates on kinetochores and chromosome arms in mitosis","volume":"1","author":"Topper","year":"2002","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bionps.2025.100120_bib162","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/CIA.S48926","article-title":"Type 2 diabetes as a risk factor for cognitive impairment: current insights","volume":"9","author":"Umegaki","year":"2014","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.bionps.2025.100120_bib163","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.bionps.2025.100120_bib164","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer\u2019s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J. Neurochem"},{"key":"10.1016\/j.bionps.2025.100120_bib165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.bionps.2025.100120_bib166","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease\u2013related blood-based biomarkers: Results from the Standardization of Alzheimer\u2019s blood biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.bionps.2025.100120_bib167","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bionps.2025.100120_bib168","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bionps.2025.100120_bib169","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bionps.2025.100120_bib170","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/jcla.21986","article-title":"SNCA gene polymorphism may contribute to an increased risk of Alzheimer\u2019s disease","volume":"30","author":"Wang","year":"2016","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.bionps.2025.100120_bib171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/brainsci14010041","article-title":"Thirty risk factors for Alzheimer\u2019s disease unified by a common neuroimmune-neuroinflammation mechanism","volume":"14","author":"Weaver","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib172","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-021-00451-6","article-title":"A blood-based diagnostic test incorporating plasma A\u03b242\/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis","volume":"16","author":"West","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bionps.2025.100120_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fradi.2021.777030","article-title":"Integrating transcriptomics, genomics, and imaging in Alzheimer\u2019s Disease: a federated model","volume":"1","author":"Wu","year":"2022","journal-title":"Front. Radio"},{"key":"10.1016\/j.bionps.2025.100120_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.879355","article-title":"Updated understanding of the crosstalk between glucose\/insulin and cholesterol metabolism","volume":"9","author":"Xiao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bionps.2025.100120_bib175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12035-014-8742-5","article-title":"The Role of SORL1 in Alzheimer\u2019s Disease","volume":"51","author":"Yin","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bionps.2025.100120_bib176","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2018.06.006","article-title":"Plasma \u03b2-amyloid1-42 reference values in cognitively normal subjects","volume":"391","author":"Zecca","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bionps.2025.100120_bib177","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","article-title":"Moving fluid biomarkers for Alzheimer\u2019s disease from research tools to routine clinical diagnostics","volume":"16","author":"Zetterberg","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bionps.2025.100120_bib178","article-title":"Shared peripheral blood biomarkers for Alzheimer\u2019s disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysis","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bionps.2025.100120_bib179","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2018.00083","article-title":"NSAID exposure and risk of Alzheimer\u2019s disease: an updated meta-analysis from cohort studies","volume":"10","author":"Zhang","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.bionps.2025.100120_bib181","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12979-024-00445-0","article-title":"Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells","volume":"21","author":"Zhang","year":"2024","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.bionps.2025.100120_bib182","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.bionps.2025.100120_bib183","doi-asserted-by":"crossref","first-page":"346","DOI":"10.14336\/AD.2017.0715","article-title":"Association of ApoE genetic polymorphism and type 2 diabetes with cognition in non-demented aging Chinese adults: a community based cross-sectional study","volume":"9","author":"Zhen","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.bionps.2025.100120_bib184","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3892\/ijmm.2023.5314","article-title":"Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites","volume":"52","author":"Zheng","year":"2023","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.bionps.2025.100120_bib185","article-title":"PET imaging of neuroinflammation in Alzheimer's disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol."}],"container-title":["Biomarkers in Neuropsychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666144625000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666144625000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:24:09Z","timestamp":1762637049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666144625000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":185,"alternative-id":["S2666144625000024"],"URL":"https:\/\/doi.org\/10.1016\/j.bionps.2025.100120","relation":{},"ISSN":["2666-1446"],"issn-type":[{"value":"2666-1446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biomarkers in Neuropsychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bionps.2025.100120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100120"}}